Skip to main content
Cesar Guerrero-Miranda, MD, Cardiology, Dallas, TX, Baylor University Medical Center

CesarYvanGuerrero-MirandaMD

Cardiology • Dallas, TX

Adult Congenital Heart Disease, Heart Failure & Transplantation

Baylor University Medical Center

Join to view full profile

Dr. Guerrero-Miranda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Guerrero-Miranda's full profile

Already have an account?

Summary

  • Dr. Cesar Guerrero-Miranda is a cardiologist in Dallas, TX and is affiliated with Baylor University Medical Center. He received his medical degree from Cayetano Heredia University and has been in practice 13 years. He specializes in advanced heart failure, cardiogenic shock, mechanical circulatory support and transplantation and is experienced in general cardiology, echocardiography, and heart failure and transplantation.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)
    Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2013
  • Rutgers Health/Newark Beth Israel Medical Center
    Rutgers Health/Newark Beth Israel Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology, 2011 - 2013
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
  • Cayetano Heredia University
    Cayetano Heredia UniversityClass of 2004

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2016 - 2025
  • NJ State Medical License
    NJ State Medical License 2011 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Mechanical Circulatory Support National Fellows Course Scholarship St. Jude, 2015
  • Henry I. Russek Travel Award American College of Cardiology (ACC), 2015
  • Minority High School Program American Heart Association (AHA), 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Antiplatelet Therapy and Adverse Hematological Events during Heart Mate II Support  
    O. Saeed, A. Shah, F. Kargoli, A. Levin, S. Patel, R. Jermyn, C.Y. Guerrero Miranda, J. Nguyen, D. Sims, J. Shin, D. D’Alessandro, D. Goldstein, U. Jorde, Circ Heart Fail, 1/1/2016

Abstracts/Posters

  • Non-invasive Endothelial Dysfunction Evaluation Through Flow-Dependent Vasodilation of the Brachial Artery Measured by Ultrasound in Controlled and non-Controlled Hype...
    C.Y. Guerrero-Miranda, F. Medina, F. Samalvides, VI International Congress of Cardiology, San Pablo Clinic, Lima, Peru, 1/1/2004
  • Detection of Mycobacterium Tuberculosis Through Polymerase Chain Reaction (PCR) in Patients with Tuberculous Pericarditis. Diagnostic Test Validation
    C.Y. Guerrero-Miranda, J. Rossell, VI International Congress of Cardiology, San Pablo Clinic, Lima, Peru, 1/1/2004

Lectures

  • Rate Responsive Pacing Improves Aerobic Exercise Capacity and 6 min Walk in CF-LVAD Patients 
    Washington, DC - 1/1/2016
  • Rate Responsive Pacing Improves Aerobic Exercise Capacity and 6 min Walk in CF-LVAD Patients 
    Washington, DC - 1/1/2016
  • Prevalence and Correlation of Non Functional Tricuspid Regurgitation to Right Ventricular Failure in Patients with CF-LVADs 
    National Harbor, MD - 1/1/2015
  • Join now to see all

Other

  • Non-invasive Endothelial Dysfunction Evaluation Through Flow-Dependent Vasodilation of the Brachial Artery Measured by Ultrasound in Controlled and non-Controlled Hype... 
    C.Y. Guerrero-Miranda
    Lima, Peru - 1/1/2004

Press Mentions

  • Natriuretic Peptides: Do They Inform the Potential for Treatment Response in HFpEF?∗
    Natriuretic Peptides: Do They Inform the Potential for Treatment Response in HFpEF?∗November 9th, 2022
  • Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure
    Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart FailureNovember 5th, 2022

Professional Memberships

Hospital Affiliations

Dr. Cesar Guerrero-Miranda, Dr. Cesar Guerrero-Miranda, MD, Dr. C Guerrero-Miranda, Dr. Cesar Yvan Guerrero-Miranda